Maroteaux-Lamy Syndrome: Clinical Trials

2 trials for Maroteaux-Lamy Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow Maroteaux-Lamy Syndrome: new trials by email Literature Review of Maroteaux-Lamy Syndrome trials Research Report on Maroteaux-Lamy Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Campath-1H, Cyclophosphamide, Busulfan - Mucopolysaccharidosis, Hurler Syndrome
Phase 2CompletedMasonic Cancer Center, University of Minnesota462009-12-012018-02-05
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Stem Cell Transplantation, Cyclophosphamide, Campath-1H - Hurler's Syndrome, Maroteaux-Lamy Syndrome
Phase 2TerminatedMasonic Cancer Center, University of Minnesota182008-03-012017-12-28

Narrower conditions

Aspartylglucosaminuria (2)  ·  Fucosidosis (2)  ·  Leukodystrophy, Globoid Cell (2)  ·  Leukodystrophy, Metachromatic (2)  ·  Mucopolysaccharidosis I (2)  ·  Mucopolysaccharidosis VI (2)  ·  Mucopolysaccharidosis VII (2)  ·  Peroxisomal Disorders (2)  ·  Sphingolipidoses (2)  ·  alpha-Mannosidosis (2)  ·  Adrenoleukodystrophy (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucopolysaccharidoses (1)  ·  Mucopolysaccharidosis II (1)  ·  Niemann-Pick Disease, Type B (1)

Broader conditions

Brain Diseases (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Carbohydrate Metabolism, Inborn Errors (2)  ·  Central Nervous System Diseases (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Connective Tissue Diseases (2)  ·  Demyelinating Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Hereditary Central Nervous System Demyelinating Diseases (2)  ·  Leukoencephalopathies (2)  ·  Lipid Metabolism Disorders (2)  ·  Lipid Metabolism, Inborn Errors (2)  ·  Lipidoses (2)  ·  Lysosomal Storage Diseases (2)

Interventions

Alemtuzumab (2)  ·  Busulfan (2)  ·  Cyclophosphamide (2)  ·  Stem Cell Transplantation (2)  ·  Bone Marrow Transplantation (1)  ·  Cyclosporine (1)  ·  Mycophenolic Acid (1)

Sponsors

Masonic Cancer Center, University of Minnesota (2)

Countries

United States (2)

Top investigators

Paul Orchard, MD (2)

Results publications

PMID 21586746